Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

PhotoCure ASA

+ Add to Watchlist

PHS:GR

3.579 EUR 0.033 0.93%

As of 13:36:21 ET on 04/24/2015.

Snapshot for PhotoCure ASA (PHS)

Open: 3.454 Day's Range: 3.454 - 3.579 Volume: 0
Previous Close: 3.546 52wk Range: 2.013 - 4.405 1-Yr Rtn: +24.14%

Stock Chart for PHS

No chart data available.
  • PHS:GR 3.579
  • 1D
  • 1M
  • 1Y
3.546
Interactive PHS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHS

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 76.57
Shares Outstanding (M) 21.39
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (NOK) 2.0000
Dividend Ex-Date 05/23/2013
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHS

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for PHS

PhotoCure ASA develops and produces pharmaceutical photodynamic therapy products and devices. The Company utilizes light-activated drugs in the treatment of cancer and other medical conditions. PhotoCure markets Metvix, a cream for the treatment of skin disorders, and the Curelight lamp to be used with the cream. The Company works with international research centers.

Kjetil HestdalPresident/CEOErik DahlChief Financial Officer
Kathleen DeardorffChief Operating OfficerInger Ferner HeglundVP:Research & Development
More Company Profile & Key Executives for PHS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil